Market
Food enzyme preparations are used in Israel as technological inputs for domestic food manufacturing (e.g., bakery and dairy processing applications). Market access is governed by Israel’s Ministry of Health (National Food Services), including requirements tied to the national list of approved food additives and a formal petition process to update that list when a substance is not yet approved. Israel functions primarily as an import-dependent market for enzyme preparations (commonly traded under HS heading 3507), supplied through registered importers and local ingredient distributors. Buyer acceptance often depends on robust identity/purity documentation aligned to international references (e.g., FAO/WHO JECFA enzyme preparation specifications) and, for some channels, kosher status considerations.
Market RoleImport-dependent ingredient market
Domestic RoleB2B input for domestic food manufacturing; supply primarily via importers and ingredient distributors under Ministry of Health import oversight
Risks
Regulatory Compliance HighIf an enzyme preparation (or its specific intended use/conditions) is not covered by Israel’s approved food additives list and is treated as a food additive, it can be blocked or delayed until the Ministry of Health review and list-update (petition) process is completed; the Ministry notes the approval process may take up to one year.Pre-screen the intended enzyme and use conditions against Israel’s approved additives framework; when not covered, submit a complete petition dossier and leverage recognized external approvals (e.g., EU/US/Codex references) to support the review.
Documentation Gap MediumIncomplete or inconsistent supporting documentation (identity/purity specifications, intended technological function, and supporting regulatory status in other jurisdictions where relevant) can extend review timelines and complicate importer clearance workflows.Align the technical dossier to the Ministry of Health petition protocol expectations and maintain a pre-shipment document checklist with the Israeli importer.
Food Safety MediumEnzyme preparations sourced from microbial/fungal production can face heightened scrutiny if toxigenicity controls, mycotoxin assurances, or production-strain characterization are not well supported in specifications, creating clearance or customer-approval risk.Provide JECFA-aligned identity/purity documentation and evidence of nonpathogenic/nontoxigenic production strains, including relevant contaminant/mycotoxin controls where applicable.
Religious Dietary MediumEnzymes of animal origin (e.g., rennet) and certain fermentation/process inputs can create kosher compliance concerns that limit sales to key Israeli food-industry buyers if certification/attestations are missing or not accepted by the customer’s authority.Engage the buyer’s kosher certifier early; document source materials, processing aids, and change-control; keep kosher certificates current per customer requirement.
Sustainability- Production-strain governance and toxigenicity controls for microbial/fungal enzyme sources (including mycotoxin risk management where relevant)
FAQ
What is the biggest regulatory blocker when marketing a new food enzyme in Israel?If the enzyme (or its specific use conditions) is treated as a food additive and is not covered by Israel’s approved food additives list, market entry can be blocked or delayed until the Ministry of Health completes its list-update (petition) review process, which the Ministry notes may take up to one year.
Which HS heading commonly covers enzyme preparations in international trade documentation for Israel?Enzyme preparations are commonly classified under HS heading 3507 (“Enzymes; prepared enzymes not elsewhere specified or included”), which includes subheadings for rennet (350710) and other enzymes/prepared enzymes (350790).
What quality documentation is most useful to support buyer and regulatory confidence for enzyme preparations?Identity and purity specifications aligned to FAO/WHO JECFA guidance are commonly used, including clear description of the source (animal/plant/microbial), assurance that microbial production strains are nonpathogenic and nontoxigenic, and relevant contaminant controls (including mycotoxin considerations for certain fungal sources).